Literature DB >> 30051372

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.

Norifumi Harimoto1,2, Tomoharu Yoshizumi3, Shoichi Inokuchi3, Shinji Itoh3, Eisuke Adachi4, Yasuharu Ikeda5, Hideaki Uchiyama6, Tohru Utsunomiya7, Kiyoshi Kajiyama8, Koichi Kimura9, Fumiaki Kishihara10, Keishi Sugimachi11, Eiji Tsujita11, Mizuki Ninomiya12, Kengo Fukuzawa13, Takashi Maeda14, Ken Shirabe15, Yoshihiko Maehara3.   

Abstract

BACKGROUND: The Controlling Nutritional Status (CONUT) score is an objective tool that is widely used to assess the nutritional status in patients, including those with cancer. The relationship between the CONUT score and prognosis in patients who have undergone hepatic resection has not been evaluated in a multi-institutional study.
METHODS: Data were retrospectively collected for 2461 consecutive patients with hepatocellular carcinoma (HCC) who had undergone hepatic resection with curative intent at 13 institutions between January 2004 and December 2015. Patients were assigned to two groups: preoperative CONUT scores ≤ 3 (low CONUT score) and ≥ 4 (high CONUT score). Clinicopathological characteristics, surgical outcomes, and long-term survival were compared using propensity score matching analysis.
RESULTS: Of the 2461 patients, 540 (21.9%) had high (≥ 4) and 1921 (78.1%) had low (≤ 3) preoperative CONUT scores. Overall, a high CONUT score was significantly associated with older age, female sex, low body mass index, low serum albumin, high serum total bilirubin, low lymphocyte count, low serum cholesterol, shorter prothrombin time, higher indocyanine green retention test at 15 min, Child-Pugh B (vs. A), liver cirrhosis, minor resection, shorter operation time, massive blood loss, blood transfusion, and postoperative complications. After propensity score matching, a higher CONUT score was significantly associated with poor overall survival (OS) and recurrence-free survival (RFS) using multivariate analysis.
CONCLUSIONS: This retrospective, multi-institutional analysis showed that, in patients who undergo curative hepatectomy for HCC, the preoperative CONUT score is predictive of worse OS and RFS, even after propensity score matching analysis.

Entities:  

Mesh:

Year:  2018        PMID: 30051372     DOI: 10.1245/s10434-018-6672-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  34 in total

1.  Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma.

Authors:  Yasuyuki Fukami; Takuya Saito; Takaaki Osawa; Takashi Arikawa; Tatsuki Matsumura; Shintaro Kurahashi; Shunichiro Komatsu; Kenitiro Kaneko; Tsuyoshi Sano
Journal:  Med Princ Pract       Date:  2020-12-24       Impact factor: 1.927

2.  Use of preoperative controlling nutritional status (CONUT) score as a better prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy.

Authors:  Fumihiro Terasaki; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2020-08-06       Impact factor: 2.549

3.  The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.

Authors:  Fumihiro Terasaki; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  Updates Surg       Date:  2020-05-15

4.  Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma.

Authors:  Yutaka Midorikawa; Tadatoshi Takayama; Masamichi Moriguchi; Rempei Yagi; Shunsuke Yamagishi; Hisashi Nakayama; Osamu Aramaki; Shintaro Yamazaki; Shingo Tsuji; Tokio Higaki
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

5.  Prognostic significance of controlling nutritional status score-based nomogram for hepatocellular carcinoma within Milan criteria after radiofrequency ablation.

Authors:  Yi Yang; Feng Ye; Yujing Xin; Yanan Wang; Xiao Li; Duiping Feng; Yi Chen; Xiang Zhou
Journal:  J Gastrointest Oncol       Date:  2020-10

6.  The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.

Authors:  Toru Aoyama; Keisuke Komori; Masato Nakazano; Kentaro Hara; Hiroshi Tamagawa; Keisuke Kazama; Itaru Hashimoto; Takanobu Yamada; Yukio Maezawa; Kenki Segami; Kazuki Kano; Shinsuke Nagasawa; Norio Yukawa; Yasushi Rino; Takashi Ogata; Takashi Oshima
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

7.  Impact of Osteopenia on Oncologic Outcomes After Curative Resection for Pancreatic Cancer.

Authors:  Takashi Motomura; Hideaki Uchiyama; Tomohiro Iguchi; Mizuki Ninomiya; Rintaro Yoshida; Takuya Honboh; Noriaki Sadanaga; Tetsuro Akashi; Hiroshi Matsuura
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers.

Authors:  Lejia Sun; Si Su; Jianping Xiong; Wenmo Hu; Lei Liu; Haifeng Xu; Shunda Du; Haitao Zhao; Xin Lu; Xinting Sang; Shouxian Zhong; Huayu Yang; Yilei Mao
Journal:  Ann Transl Med       Date:  2021-04

9.  Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab.

Authors:  Taro Ohba; Shinkichi Takamori; Ryo Toyozawa; Kaname Nosaki; Yasuhiro Umeyama; Naoki Haratake; Naoko Miura; Masafumi Yamaguchi; Kenichi Taguchi; Takashi Seto; Mototsugu Shimokawa; Mitsuhiro Takenoyama
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

10.  Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?

Authors:  Lukas Müller; Felix Hahn; Aline Mähringer-Kunz; Fabian Stoehr; Simon J Gairing; Friedrich Foerster; Arndt Weinmann; Peter R Galle; Jens Mittler; Daniel Pinto Dos Santos; Michael B Pitton; Christoph Düber; Roman Kloeckner
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.